-
1
-
-
0026747176
-
Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease
-
Smith CA, Gough AC, Leigh PN, et al. Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease. Lancet, 1992, 339: 1375-1377.
-
(1992)
Lancet
, vol.339
, pp. 1375-1377
-
-
Smith, C.A.1
Gough, A.C.2
Leigh, P.N.3
-
2
-
-
0027464780
-
Association of a monoamine oxidase B allele with Parkinson's disease
-
Kurth JH, Kurth MC, Poduslo SE. Association of a monoamine oxidase B allele with Parkinson's disease. Ann Neurol, 1993, 33: 368-372.
-
(1993)
Ann Neurol
, vol.33
, pp. 368-372
-
-
Kurth, J.H.1
Kurth, M.C.2
Poduslo, S.E.3
-
3
-
-
0023263921
-
Clues from epidemiology of Parkinson's disease
-
Marttila RJ, Rinne UK. Clues from epidemiology of Parkinson's disease. Adv Neurol, 1987, 45: 285-288.
-
(1987)
Adv Neurol
, vol.45
, pp. 285-288
-
-
Marttila, R.J.1
Rinne, U.K.2
-
4
-
-
0030692086
-
Association of slow acetylator genotype for N-acetyltransferase 2 with familial Parkinson's disease
-
Bandmann O, Vaughan J, Holmans P. Association of slow acetylator genotype for N-acetyltransferase 2 with familial Parkinson's disease. Lancet, 1997, 350: 1136-1139.
-
(1997)
Lancet
, vol.350
, pp. 1136-1139
-
-
Bandmann, O.1
Vaughan, J.2
Holmans, P.3
-
5
-
-
0020680904
-
Chronic parkinsonism in humans due to a product of meperidine-analog synthsis
-
Langsten JW, Ballard P, Tetrud JW. Chronic parkinsonism in humans due to a product of meperidine-analog synthsis. Science, 1983, 219: 979-980.
-
(1983)
Science
, vol.219
, pp. 979-980
-
-
Langsten, J.W.1
Ballard, P.2
Tetrud, J.W.3
-
6
-
-
0023224837
-
Biochemical events in the developments of parkinsonism induced by 1-methyl-4-phenyl-1,2,3, 6-tetra hydropyridine
-
Singer TP, Castagnoli N Jr, Ramsay RR. Biochemical events in the developments of parkinsonism induced by 1-methyl-4-phenyl-1,2,3, 6-tetra hydropyridine. J Neurochem, 1987, 49: 1-8.
-
(1987)
J Neurochem
, vol.49
, pp. 1-8
-
-
Singer, T.P.1
Castagnoli Jr., N.2
Ramsay, R.R.3
-
7
-
-
0021182244
-
Pargyline prevents MPTP-induced parkinsonism in primates
-
Langsten JW, Irwin I, Langsten EB. Pargyline prevents MPTP-induced parkinsonism in primates. Science, 1984, 225: 1480-1482.
-
(1984)
Science
, vol.225
, pp. 1480-1482
-
-
Langsten, J.W.1
Irwin, I.2
Langsten, E.B.3
-
8
-
-
0021280826
-
Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine in mice
-
Heikkila RE, Hess A, Duvoisin RC. Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. Science, 1984, 224: 1451-1453.
-
(1984)
Science
, vol.224
, pp. 1451-1453
-
-
Heikkila, R.E.1
Hess, A.2
Duvoisin, R.C.3
-
9
-
-
0024948366
-
The endogenous toxin hypothesis of the etiology of Parkinson's disease and a pilot trial of high-dosage antioxidants in an attempt to slow the progression of the illness
-
Fahn S. The endogenous toxin hypothesis of the etiology of Parkinson's disease and a pilot trial of high-dosage antioxidants in an attempt to slow the progression of the illness. Ann N Y Acad Sci, 1989, 570: 186-196.
-
(1989)
Ann N Y Acad Sci
, vol.570
, pp. 186-196
-
-
Fahn, S.1
-
10
-
-
0024429175
-
Neurochemical perspectives of the function of monoamine oxidases
-
Riederer P, Konradi C, Hebenstreit G. Neurochemical perspectives of the function of monoamine oxidases. Psychiatr Prax, 1989, 16 Suppl 1: 7-10.
-
(1989)
Psychiatr Prax
, vol.16
, Issue.SUPPL. 1
, pp. 7-10
-
-
Riederer, P.1
Konradi, C.2
Hebenstreit, G.3
-
11
-
-
0023188570
-
Monoamine oxidase, hydrogen peroxide, and Parkinson's disease
-
Cohen G. Monoamine oxidase, hydrogen peroxide, and Parkinson's disease. Adv Neurol, 1987, 45: 119-125.
-
(1987)
Adv Neurol
, vol.45
, pp. 119-125
-
-
Cohen, G.1
-
12
-
-
0020683252
-
Deprenyl leads to prolongation of L-dopa efficacy in Parkinson's disease
-
Birkmayer W, Knoll J, Riederer P. Deprenyl leads to prolongation of L-dopa efficacy in Parkinson's disease. Mod Probl Pharmacopaychiatry, 1983, 19: 170-176.
-
(1983)
Mod Probl Pharmacopaychiatry
, vol.19
, pp. 170-176
-
-
Birkmayer, W.1
Knoll, J.2
Riederer, P.3
-
13
-
-
0025875460
-
Selegiline (deprenyl) treatment and death of nigral neurons in Parkinson's disease
-
Rinne JO, Roytta M, Paljarvi L, et al. Selegiline (deprenyl) treatment and death of nigral neurons in Parkinson's disease. Neurology, 1991, 41: 859-861.
-
(1991)
Neurology
, vol.41
, pp. 859-861
-
-
Rinne, J.O.1
Roytta, M.2
Paljarvi, L.3
-
14
-
-
0016829477
-
Effects of monoamine oxidase inhibition by clorgyline, deprenil or tranylcypromine on 5-hydroxytryptamine concentrations in rat brain and hyperactivity following subsequent tryptophan administration
-
Green AR, Youdim MB. Effects of monoamine oxidase inhibition by clorgyline, deprenil or tranylcypromine on 5-hydroxytryptamine concentrations in rat brain and hyperactivity following subsequent tryptophan administration. Br J Pharmacol, 1975, 55: 415-422.
-
(1975)
Br J Pharmacol
, vol.55
, pp. 415-422
-
-
Green, A.R.1
Youdim, M.B.2
-
15
-
-
0024353056
-
Molecular genetics of the monoamine oxidases
-
Hsu YP, Powell JF, Sims KB, et al. Molecular genetics of the monoamine oxidases. Neurochem, 1989, 53: 12-18.
-
(1989)
Neurochem
, vol.53
, pp. 12-18
-
-
Hsu, Y.P.1
Powell, J.F.2
Sims, K.B.3
-
16
-
-
4644251703
-
-
Chinese source
-
-
-
-
17
-
-
4644237164
-
-
Chinese source
-
-
-
-
18
-
-
0033546602
-
Parkinson's disease, MAOB, and smoking
-
Mellick GD, McCann SJ, Le Couter DG. Parkinson's disease, MAOB, and smoking [letter]. Neurology, 1999, 53: 658.
-
(1999)
Neurology
, vol.53
, pp. 658
-
-
Mellick, G.D.1
McCann, S.J.2
Le Couter, D.G.3
-
19
-
-
0036461061
-
Investigation of the functional effect of monoamine oxidase polymorphisms in human brain
-
Balciuniene J, Emilsson L, Oreland L. Investigation of the functional effect of monoamine oxidase polymorphisms in human brain. Hum Genet, 2002, 110: 1-7.
-
(2002)
Hum Genet
, vol.110
, pp. 1-7
-
-
Balciuniene, J.1
Emilsson, L.2
Oreland, L.3
-
20
-
-
0029610818
-
Association analysis of a polymorphism of the monoamine oxidase B gene with Parkinson's disease in a Japanese population
-
Morimoto Y, Murayama N, Kuwano A, et al. Association analysis of a polymorphism of the monoamine oxidase B gene with Parkinson's disease in a Japanese population. Am J Med Genet, 1995, 60: 570-572.
-
(1995)
Am J Med Genet
, vol.60
, pp. 570-572
-
-
Morimoto, Y.1
Murayama, N.2
Kuwano, A.3
-
21
-
-
0037076476
-
MAOB intron 13 and COMT codon 158 polymorphisms, cigarette smoking, and the risk of PD
-
Hernan MA, Checkoway H, O'Brien R, et al. MAOB intron 13 and COMT codon 158 polymorphisms, cigarette smoking, and the risk of PD. Neurology, 2002, 58: 1381-1387.
-
(2002)
Neurology
, vol.58
, pp. 1381-1387
-
-
Hernan, M.A.1
Checkoway, H.2
O'Brien, R.3
|